Cover Image
市場調查報告書

中國的遺傳基因檢驗市場預測

China Genetic Testing Market Outlook to 2021

出版商 GlobalData 商品編碼 346055
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
中國的遺傳基因檢驗市場預測 China Genetic Testing Market Outlook to 2021
出版日期: 2015年08月14日 內容資訊: 英文 27 Pages
簡介

本報告提供中國的遺傳基因檢驗市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 中國的遺傳基因檢驗市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 中國的主要企業概要:遺傳基因檢驗市場

  • 企業概要
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Abbott Laboratories
    • Siemens Healthcare
    • Hologic, Inc.
    • Transgenomic, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen N.V.

第5章 遺傳基因檢驗市場開發中產品

第6章 財務交易形勢

  • 夥伴關係

第7章 附錄

圖表

目錄
Product Code: GDMECC1244DB

GlobalData's new report, "China Genetic Testing Market Outlook to 2021", provides key market data on the China Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Genetic Testing market.
  • Global corporate-level profiles of key companies operating within the China Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Genetic Testing Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Genetic Testing Market, China

  • 3.1. Genetic Testing Market, China, Revenue ($m), 2007-2014
  • 3.2. Genetic Testing Market, China, Revenue ($m), 2014-2021
  • 3.3. Genetic Testing Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 3.4. Genetic Testing Market, China, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in China, Genetic Testing Market

  • 4.1. F. Hoffmann-La Roche Ltd.
    • 4.1.1. Company Overview
  • 4.2. Danaher Corporation
    • 4.2.1. Company Overview
  • 4.3. Abbott Laboratories
    • 4.3.1. Company Overview
  • 4.4. Siemens Healthcare
    • 4.4.1. Company Overview
  • 4.5. Hologic, Inc.
    • 4.5.1. Company Overview
  • 4.6. Transgenomic, Inc.
    • 4.6.1. Company Overview
  • 4.7. Bio-Rad Laboratories, Inc.
    • 4.7.1. Company Overview
  • 4.8. Qiagen N.V.
    • 4.8.1. Company Overview

5. Genetic Testing Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Partnerships
    • 6.1.1. Genomic Vision Extends Agreement with Quest Diagnostics
    • 6.1.2. Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
    • 6.1.3. Hibergene Diagnostics Enters into Licensing Agreement with Eiken for LAMP

7. Appendix

  • 7.1. Research Methodology
    • 7.1.1. Coverage
    • 7.1.2. Secondary Research
    • 7.1.3. Primary Research
    • 7.1.4. Company Share Analysis
    • 7.1.5. Distribution Share Analysis
  • 7.2. GlobalData Consulting
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 4: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 5: Genetic Testing Market Pipeline Products
  • Table 6: Genomic Vision Extends Agreement with Quest Diagnostics
  • Table 7: Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech
  • Table 8: Hibergene Diagnostics Enters into Licensing Agreement with Eiken for LAMP

List of Figures

  • Figure 1: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Genetic Testing Market, China, Company Share (%) 2014
Back to Top